In addition, HCC patients with a lower expression of FDX1 is associated with shorter survival time (Figures 1H–J) probably due to the gain of survival advantage of these tumor cells by resisting against copper-induced toxicity. The gene discussed is FDX1; the disease is hepatocellular carcinoma.